Live feed07:00:00·8dPRReleasevia QuantisnowRadiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026ByQuantisnow·Wall Street's wire, on your screen.RADX· Radiopharm Theranostics LimitedHealth Care
